Can a 9‑month‑old who has fully recovered from measles receive the DTaP (diphtheria‑pertussis‑tetanus) vaccine now?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DTaP Vaccination for a 9-Month-Old After Measles Recovery

Yes, a 9-month-old who has fully recovered from measles can and should receive DTaP vaccine now, as there are no contraindications to administering DTaP after measles infection or measles vaccination. 1

Key Vaccination Principles

DTaP can be administered regardless of recent illness or other vaccine timing. The standard DTaP schedule for infants includes doses at 2,4,6, and 15-18 months of age, with a fifth dose at 4-6 years. 1 For a 9-month-old, you should focus on ensuring the child has received the first three doses of the primary series.

Specific Recommendations for This 9-Month-Old

  • Verify the child's current DTaP status and administer any missing doses from the primary series (doses 1,2, or 3) immediately. 1

  • There is no minimum interval required between measles illness recovery and DTaP administration. Once the child has clinically recovered from acute measles infection, vaccination can proceed. 1

  • If doses are delayed, do not restart the series. The vaccination series never needs to be restarted regardless of how much time has elapsed between doses. 1

Catch-Up Vaccination Schedule

  • For children with incomplete vaccination history, administer DTaP doses with minimum intervals of 4 weeks between doses 1 and 2, and between doses 2 and 3. 1

  • The fourth dose should be given at least 6 months after the third dose, typically at 15-18 months of age. 1

  • An accelerated schedule can be used if needed, with doses administered at 4-week intervals, though 8-week intervals are preferred. 1

Important Safety Considerations

  • DTaP is significantly safer than whole-cell DTP, with substantially reduced local reactions, fever, and systemic events. 1, 2

  • Local reactions increase with successive doses, but this is expected and not a contraindication to continuing the series. 2

  • Undervaccination (receiving fewer than recommended doses) is associated with 4.8 times higher risk of pertussis for the 3-dose primary series, making timely completion critical. 3

Common Pitfalls to Avoid

  • Do not confuse recent measles infection with a contraindication to DTaP. Measles infection does not preclude DTaP administration once the child has recovered. 1

  • Do not delay DTaP vaccination unnecessarily. While short delays may be less critical if the age-appropriate number of doses is eventually administered, ensuring children receive all doses is paramount for protection. 3

  • Do not exceed 6 total doses of diphtheria-tetanus containing vaccines before the seventh birthday. Only documented doses count toward this maximum. 1

  • Ensure you are using DTaP (not Tdap) for this age group. DTaP is the appropriate formulation for children under 7 years of age. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.